(Q33555911)

28 July 2017

title

Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults (English)

1 reference

28 July 2017

0 references

7

Gale Smith

1 reference

28 July 2017

Louis Fries

1

1 reference

28 July 2017

Vivek Shinde

2

1 reference

28 July 2017

Jeffrey J Stoddard

3

1 reference

28 July 2017

D Nigel Thomas

4

1 reference

28 July 2017

Eloi Kpamegan

5

1 reference

28 July 2017

Hanxin Lu

6

1 reference

28 July 2017

Somia P Hickman

8

1 reference

28 July 2017

Pedro Piedra

9

1 reference

28 July 2017

Gregory M Glenn

10

1 reference

28 July 2017

publication date

12 April 2017

1 reference

28 July 2017

1 reference

28 July 2017

volume

14

1 reference

28 July 2017

page(s)

8

1 reference

Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Respiratory syncytial virus infection in older adults: an under-recognized problem

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Respiratory syncytial virus infection in adult populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Respiratory syncytial virus infection in elderly and high-risk adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5389002

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

Serum antibody decay in adults following natural respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12979-017-0090-7

10.1186/S12979-017-0090-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference